Reporting person on SEC Form 4

Roy Galvin

Roy Galvin is EVP, Chief Commercial Officer at Haemonetics. OQRO lists 3 transactions filed with the SEC under this name, the latest on May 19, 2026, each linked to the official Form 4.

EVP, Chief Commercial Officer

Disclosures on record

3

Companies involved

1

Disclosure history

HaemoneticsHAE
3 disclosures · Nov 2025 – May 2026
- May 15, 202628Kdisclosed May 19
  Details Official record
- May 15, 2026879disclosed May 19
  Details Official record

Oct 31, 2025145disclosed Nov 3

Details Official record

All activity in Haemonetics